Autoimmunity
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 4.3 | Q2 | 65.6% | 1.035 | Q2 | 84.8% |
| 2024 | 3.1 | Q2 | 52.2% | 0.842 | Q2 | 79.4% |
| 2023 | 3.3 | Q3 | 44.9% | 0.741 | Q2 | 77.4% |
| 2022 | 3.5 | Q3 | 37.5% | 0.625 | Q3 | 73.3% |
| 2021 | 3.0 | Q4 | 28.1% | 0.590 | Q3 | 72.4% |
| 2020 | — | — | 0.623 | Q3 | 72.8% | |
| 2019 | — | — | 0.799 | Q3 | 80.3% | |
| 2018 | — | — | 0.866 | Q2 | 80.6% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1607-842X
ISSN
0891-6934
country
GBcoverage
1988-2026